MPPE1 and urothelial carcinoma: Owing to this, some researchers suggest that chemotherapy agents that are effective for urothelial carcinoma may also benefit patients with metastatic CDC1,12 Tokuda et al. and Motzer et al. found that patients with metastatic CDC could exhibit a partial response to gemcitabine and either cisplatin or carboplatin therapy8,13.